More aggressive high-grade lymphomas are treated for cure. Although chemotherapy and radiotherapy remain the mainstays of treatment, immunotherapy demonstrates increasing promise.Reed-Sternberg Cells
Non-Hodgkin's-lymphoma, treatmentProduct-approvalsRituximab, therapeutic useBACKGROUND: Rituximab, a monoclonal anti-CD20 antibody, in combination with chemotherapy improves overall survival compared to chemotherapy alone when used for induction therapy for patients with newly diagnosed or relapsed indolent ...